Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Intensity Therapeutics Inc. (INTS) had Debt to Capital Ratio of 0.04 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.54M |
|
-- |
|
-- |
|
$2.71M |
|
$-2.71M |
|
$0.17M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.71M |
|
$-2.70M |
|
18.87M |
|
18.87M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$3.04M |
|
-- |
|
$1.41M |
|
$4.44M |
|
$2.16M |
|
$0.10M |
|
$0.10M |
|
$2.26M |
|
$2.18M |
|
$2.18M |
|
$2.18M |
|
26.17M |
|
| Cash Flow Statement Financials | |
$-4.45M |
|
-- |
|
$4.07M |
|
$2.59M |
|
$2.22M |
|
$-0.37M |
|
$1.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.04 |
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-116.16% |
|
-116.16% |
|
-57.10% |
|
-111.32% |
|
$0.08 |
|
$-0.24 |
|
$-0.24 |
|